Moh Authorizes Use Of Bamlanivimab To Treat Mild To Moderate Cases Of Covid

01 December 2020 Coronavirus

Kuwait’s Ministry of Health (MoH) authorized the drug “Bamlanivimab” for emergency use to treat mild to moderate cases of COVID-19 in adult patients and kids over 12 years old who have risk factors that make them more vulnerable.
Assistant Undersecretary for Drug and Food Control Affairs Dr Abdullah Al- Bader said, in a press statement on Tuesday, that the last emergency use of Baricitinib was licensed to be used as an added drug to Remdesivir to treat COVID-19 cases in adult patients and children over two years old who are receiving hospital treatment with ventilators. (KUNA)
 

SOURCE: ARABTIMES KUWAIT

: 555

Comments Post Comment

Leave a Comment